Activity ID
14520Expires
February 15, 2027Format Type
EnduringCME Credit
0.5Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
The goal of this activity is to improve the knowledge, competence, and performance of learners in an effort to optimize treatment for patients with Multiple Sclerosis.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
YesNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Upon completion of this activity, participants should be able to:
Identify the immunopathogenic mechanisms and biologic basis of MS in the context of available treatment options
Evaluate clinical trial data on approved and emerging DMTs for relapsing MS
Apply efficacy, safety, and disease activity metrics to tailor treatment selection and monitoring plans for relapsing MS
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Outpatient, Rural, Urban, VA/Military
